SIRT1 and chronic myelogenous leukemia, BCR-ABL1 positive: The role of SIRT1 was demonstrated in a study in CML mouse models and showed that when SIRT1 was deleted in these mice, it impaired the leukemia development, and TKIs were more effective in SIRT1-deleted mice [43].